C41.0 Malignant neoplasm, bones of skull and face

Add Analogs Compare

Found partially in the 44 (33) ⓘ✘Found partially in the 44 drug (33 of these, according to Kiberis statistics) in 41 selected books (authors) ... hide

Effect Influence Cases ⓘ ✘ Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.

c41.0 malignant neoplasm, bones of skull and face
66%+5%11 read Verbascum thapsus hahnemanni
59%+13%58 read Apis mellifica
Face - E 59% (I 13%, 58 cases.); Skull - E 76% (I 21%, 5 cases.)
52%+29%15 read Stannum metallicum
51%+13%13 read Asafoetida
49%-5%14 read Platinum metallicum
48%+11%40 read Phytolacca decandra
46%+5%7 read Selenium
46%+5%26 read Magnesia muriatica
44%+28%34 read Argentum metallicum
43%+16%119 read Kali bichromicum
Face - E 43% (I 16%, 119 cases.); Skull - E 50% (I 2%, 14 cases.)
43%-9%15 read Tabacum
42%+11%287 read Sepia officinalis
Face - E 42% (I 11%, 287 cases.); Skull - E 85% (I 25%, 10 cases.)
40%+5%289 read Kalium carbonicum
Face - E 40% (I 5%, 289 cases.); Skull - E 56% (I 6%, 25 cases.)
40%+4%553 read Phosphorus
Face - E 40% (I 4%, 553 cases.); Skull - E 58% (I 11%, 24 cases.)
39%+1%22 read Colocynthis
38%+4%207 read Causticum hahnemanni
Face - E 38% (I 4%, 207 cases.); Skull - E 41% (I 10%, 7 cases.)
38%+13%128 read Staphysagria
38%-3%7 read Mercurius corrosivus
36%+5%437 read Lycopodium clavatum
Face - E 36% (I 5%, 437 cases.); Skull - E 36% (I 6%, 22 cases.)
36%+5%557 read Natrum muriaticum
Face - E 36% (I 5%, 557 cases.); Skull - E 56% (I 11%, 18 cases.)
35%+3%403 read Lachesis muta
Face - E 35% (I 3%, 403 cases.); Skull - E 45% (I 5%, 32 cases.)
35%+23%13 read Kali nitricum
34%+1%55 read Spigelia anthelmia
Face - E 34% (I 1%, 55 cases.); Skull - E 88% (I 32%, 5 cases.)
33%+3%72 read Argentum nitricum
33%+5%347 read Arsenicum album
Face - E 33% (I 5%, 347 cases.); Skull - E 49% (I 1%, 18 cases.)
32%+3%20 read Iris versicolor
30%-10%16 read Aurum metallicum
30%+1%76 read Gelsemium sempervirens
29%+6%331 read Calcarea carbonica
Face - E 29% (I 6%, 331 cases.); Skull - E 35% (I 15%, 16 cases.)
27%-21%16 read Discus compositum
23%-6%78 read Mercurius solubilis
Face - E 23% (I -6%, 78 cases.); Skull - E 25% (I -3%, 7 cases.)
8%+10%20 read Kali iodatum
0%+3%3 read Clematic erecta
Antipyrinum read
Arsenicum metallicum read
Capsicum annuum read
Curare woorari read
Hippozaeninum read
Lachnanthes tinctoria read
Magnesia sulphurica read
Mygale lasiodora read
Pediculus capitis read
Piper nigrum read
Rheum palmatum read

Other names and synonyms

C41.0.

C41.0 Malignant neoplasm, bones of skull and face

Description

There is no detailed description, see related

Related diseases

C41.0 Malignant neoplasm, bones of skull and face

Related clinical guidelines

Related standards of medical care

✘Available only when using PRO account

Content moderator: Vasin A. S.

Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
Nothing in the information provided should be interpreted as a call to use these drugs.
No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.